PLUS THERAPEUTICS, INC. — Director's Dealing 2016

Jan 4, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2016-01-04

Reporting Person: Girao Tiago (VP & Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-04	Employee Stock Option	$	A	349830	Acquired	2026-01-04	Common Stock (349830)	Direct

Footnotes

F1: The reporting person received an incentive stock option granted under the Corporation's 2014 Equity Incentive Plan. The exercise price per share to be paid by the reporting person at the time the option is exercised shall be the closing sale price of the Corporation's Common Stock on the NASDAQ Stock Market as of the date of the grant. The closing sale price is $0.1872.

F2: Twenty percent (25%) of the option shares shall vest on January 4, 2017 with the remaining option shares vesting in 36 equal monthly installments thereafter.